Company Filing History:
3 out of 263 
1 out of 15,475 
Years Active: 2017-2020
Title: Innovations of Kip M Connor
Introduction
Kip M Connor is an accomplished inventor based in Newton, MA. He has made significant contributions to the field of biomedical research, particularly in the area of inflammation and angiogenesis. With a total of 3 patents, his work has the potential to impact various medical conditions.
Latest Patents
Connor's latest patents focus on stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase. These disclosures relate to methods for reducing inflammation, angiogenesis, vascular leakage, and neovascularization. By administering stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase, he aims to treat disorders associated with these conditions. His research also includes methods for reducing angiogenesis and inflammation using epoxymetabolites of Docosahexaenoic acid and Eicosapentaenoic acid, which could be beneficial for conditions like age-related macular degeneration, cancer, stroke, and arthritis.
Career Highlights
Throughout his career, Kip M Connor has worked with prestigious institutions such as the Massachusetts Eye and Ear Infirmary and the University of California. His research has been pivotal in advancing our understanding of lipid metabolites and their role in inflammation and vascular health.
Collaborations
Connor has collaborated with notable colleagues, including Ryoji Yanai and Eiichi Hasegawa, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Kip M Connor's work exemplifies the intersection of innovation and medical research, with his patents paving the way for new treatments in inflammation and angiogenesis. His contributions are significant and continue to influence the biomedical landscape.